Your browser doesn't support javascript.
loading
Introduction of SARS-CoV-2 C.37 (WHO VOI lambda) in the Sao Paulo State, Southeast Brazil.
Kashima, Simone; Slavov, Svetoslav N; Giovanetti, Marta; Rodrigues, Evandra S; Patané, José S L; Viala, Vincent L; Santos, Elaine V; Evaristo, Mariane; de Lima, Loyze P O; Martins, Antonio J; Dos Santos Barros, Claudia R; Marqueze, Elaine C; Garibaldi, Pedro M M; Ferreira, Natasha N; Moraes, Glenda R; Brassaloti, Ricardo A; Cassano, Raquel L R C; Mariani, Pilar D S C; Kitajima, João P; Schlesinger, David; Bezerra, Rafael S; Assato, Patricia A; da Costa, Felipe A S; Poleti, Mirele Daiana; Lesbon, Jessika C C; Mattos, Elisangela C; Banho, Cecilia A; Sacchetto, Lívia; Grotto, Rejane M T; Souza-Neto, Jayme A; Fonseca, Vagner; de Alcantara, Luiz C J; Nogueira, Maurício L; Fukumasu, Heidge; Coutinho, Luiz L; Borges, Marcos; Calado, Rodrigo T; Elias, Maria C; Sampaio, Sandra C; Covas, Dimas T.
Afiliação
  • Kashima S; Blood Center of Ribeirão Preto, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
  • Slavov SN; Blood Center of Ribeirão Preto, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
  • Giovanetti M; Butantan Institute, São Paulo, Brazil.
  • Rodrigues ES; Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
  • Patané JSL; Instituto Oswaldo Cruz (FIOCRUZ), Rio de Janeiro, Brazil.
  • Viala VL; Blood Center of Ribeirão Preto, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
  • Santos EV; Butantan Institute, São Paulo, Brazil.
  • Evaristo M; Butantan Institute, São Paulo, Brazil.
  • de Lima LPO; Blood Center of Ribeirão Preto, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
  • Martins AJ; Blood Center of Ribeirão Preto, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
  • Dos Santos Barros CR; Butantan Institute, São Paulo, Brazil.
  • Marqueze EC; Butantan Institute, São Paulo, Brazil.
  • Garibaldi PMM; Butantan Institute, São Paulo, Brazil.
  • Ferreira NN; Butantan Institute, São Paulo, Brazil.
  • Moraes GR; Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
  • Brassaloti RA; Serrana State Hospital, Serrana, Brazil.
  • Cassano RLRC; Serrana State Hospital, Serrana, Brazil.
  • Mariani PDSC; Epidemic Service, Serrana, Brazil.
  • Kitajima JP; Centro de Genômica Funcional da ESALQ, University of São Paulo, Piracicaba, SP, Brazil.
  • Schlesinger D; Centro de Genômica Funcional da ESALQ, University of São Paulo, Piracicaba, SP, Brazil.
  • Bezerra RS; NGS Soluções Genômicas, Piracicaba, SP, Brazil.
  • Assato PA; Mendelics Análise Genômica SA, Sao Paulo, Brazil.
  • da Costa FAS; Mendelics Análise Genômica SA, Sao Paulo, Brazil.
  • Poleti MD; Blood Center of Ribeirão Preto, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
  • Lesbon JCC; Department of Bioprocesses and Biotechnology, School of Agricultural Sciences, São Paulo State University (UNESP), Botucatu, Brazil.
  • Mattos EC; Department of Bioprocesses and Biotechnology, School of Agricultural Sciences, São Paulo State University (UNESP), Botucatu, Brazil.
  • Banho CA; Department of Veterinary Medicine, School of Animal Science and Food Engineering, University of Sao Paulo, Pirassununga, Brazil.
  • Sacchetto L; Department of Veterinary Medicine, School of Animal Science and Food Engineering, University of Sao Paulo, Pirassununga, Brazil.
  • Grotto RMT; Department of Veterinary Medicine, School of Animal Science and Food Engineering, University of Sao Paulo, Pirassununga, Brazil.
  • Souza-Neto JA; Medicine School of São José do Rio Preto (FAMERP), São José do Rio Preto, São Paulo, Brazil.
  • Fonseca V; Medicine School of São José do Rio Preto (FAMERP), São José do Rio Preto, São Paulo, Brazil.
  • de Alcantara LCJ; School of Agricultural Sciences, São Paulo State University (UNESP), Botucatu, Brazil.
  • Nogueira ML; Molecular Biology Laboratory, Applied Biotechnology Laboratory, Clinical Hospital of the Botucatu Medical School, Botucato, Brazil.
  • Fukumasu H; School of Agricultural Sciences, São Paulo State University (UNESP), Botucatu, Brazil.
  • Coutinho LL; Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
  • Borges M; Coordenação Geral de Laboratórios de Saúde Pública/Secretaria de Vigilância em Saúde, Ministério da Saúde, (CGLAB/SVS-MS) Brasília, Brazil.
  • Calado RT; Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
  • Elias MC; Instituto Oswaldo Cruz (FIOCRUZ), Rio de Janeiro, Brazil.
  • Sampaio SC; Medicine School of São José do Rio Preto (FAMERP), São José do Rio Preto, São Paulo, Brazil.
  • Covas DT; Department of Veterinary Medicine, School of Animal Science and Food Engineering, University of Sao Paulo, Pirassununga, Brazil.
J Med Virol ; 94(3): 1206-1211, 2022 03.
Article em En | MEDLINE | ID: mdl-34647634
The Lambda variants of interest (VOI) (C37/GR/452Q.V1/21G) was initially reported in Lima, Peru but has gained rapid dissemination through other Latin American countries. Nevertheless, the dissemination and molecular epidemiology of the Lambda VOI in Brazil is unknown apart from a single case report. In this respect, we characterized the circulation of the SARS-CoV-2 Lambda VOI (C37/GR/452Q.V1/21G) in Sao Paulo State, Brazil. From March to June 2021, we identified seven Lambda isolates in a set of approximately 8000 newly sequenced genomes of the Network for Pandemic Alert of Emerging SARS-CoV-2 variants from Sao Paulo State. Interestingly, in three of the positive patients, the Lambda VOI infection was probably related to a contact transmission. These individuals were fully vaccinated to COVID-19 and presented mild symptoms. The remaining positive for Lambda VOI individuals showed different levels of COVID-19 symptoms and one of them needed hospitalization (score 5, WHO). In our study, we present a low level of Lambda VOI circulation in the Sao Paulo State. This reinforces the essential role of molecular surveillance for the effective SARS-CoV-2 pandemic response, especially in regard to circulating variants.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Tipo de estudo: Prognostic_studies Limite: Humans País/Região como assunto: America do sul / Brasil Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Tipo de estudo: Prognostic_studies Limite: Humans País/Região como assunto: America do sul / Brasil Idioma: En Ano de publicação: 2022 Tipo de documento: Article